1.14.99.1	11beta-hydroxysteroid dehydrogenase deficiency	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15718388&form=6&db=m	Interactions between 11beta-hydroxysteroid dehydrogenase and COX-2 in kidney.	causal interaction,ongoing research,unassigned	4,4,0	
1.14.99.1	Aberrant Crypt Foci	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8601574&form=6&db=m	Suppression of azoxymethane-induced aberrant crypt foci in rat colon by nimesulide, a selective inhibitor of cyclooxygenase 2.	causal interaction,therapeutic application,unassigned	3,4,0	
1.14.99.1	Aberrant Crypt Foci	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8840961&form=6&db=m	Evaluation of cyclooxygenase-2 inhibitor for potential chemopreventive properties in colon carcinogenesis.	causal interaction,ongoing research,therapeutic application,unassigned	4,1,4,0	
1.14.99.1	Aberrant Crypt Foci	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9149043&form=6&db=m	Aspirin, but not sodium salicylate, indomethacin, or nabumetone, reversibly suppresses 1,2-dimethylhydrazine-induced colonic aberrant crypt foci in rats.	ongoing research,therapeutic application,unassigned	3,1,0	
1.14.99.1	Aberrant Crypt Foci	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9439679&form=6&db=m	Inhibitory effect of NS-398, a selective cyclooxygenase-2 inhibitor, on azoxymethane-induced aberrant crypt foci in colon carcinogenesis of F344 rats.	causal interaction,ongoing research,therapeutic application,unassigned	4,4,4,0	
1.14.99.1	Aberrant Crypt Foci	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9458081&form=6&db=m	Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis.	causal interaction,therapeutic application,unassigned	4,4,0	
1.14.99.1	Aberrant Crypt Foci	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10893436&form=6&db=m	Suppressive effect of the herbal medicine Oren-gedoku-to on cyclooxygenase-2 activity and azoxymethane-induced aberrant crypt foci development in rats.	ongoing research,unassigned	2,0	
1.14.99.1	Aberrant Crypt Foci	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11197048&form=6&db=m	Non-steroidal anti-inflammatory drugs with different cyclooxygenase inhibitory profiles that prevent aberrant crypt foci formation but vary in acute gastrotoxicity in a rat model.	ongoing research,therapeutic application,unassigned	1,4,0	
1.14.99.1	Aberrant Crypt Foci	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11216473&form=6&db=m	COX-2 and iNOS, good targets for chemoprevention of colon cancer.	causal interaction,ongoing research,therapeutic application,unassigned	4,3,4,0	
1.14.99.1	Aberrant Crypt Foci	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11280748&form=6&db=m	Modulation of experimental colon tumorigenesis by types and amounts of dietary fatty acids.	causal interaction,diagnostic usage,ongoing research,therapeutic application	4,3,3,1